A Prospective, Single Center, Randomized, Double-blind, Placebo Controlled Study in Two Phases to Evaluate the Safety and Efficacy of ATx201 as a Topical Antibiotic Agent
Phase of Trial: Phase I/II
Latest Information Update: 10 Aug 2017
At a glance
- Drugs Niclosamide (Primary)
- Indications Atopic dermatitis; Bacterial skin diseases; Eczema
- Focus Adverse reactions; First in man
- Acronyms DECOLAD
- Sponsors AntibioTx
- 07 Aug 2017 Planned End Date changed from 1 May 2017 to 1 Oct 2017.
- 07 Aug 2017 Planned primary completion date changed from 1 May 2017 to 1 Aug 2017.
- 05 Jun 2017 Last checked against European Clinical Trials Database record.